Author
Listed:
- Pascal M. Mutie
(Lund University, Skåne University Hospital)
- Hugo Pomares-Millan
(Lund University, Skåne University Hospital)
- Naeimeh Atabaki-Pasdar
(Lund University, Skåne University Hospital)
- Nina Jordan
(Regulatory Affairs Intelligence, Novo Nordisk A/S)
- Rachel Adams
(Regulatory Affairs—Neuroscience and Cardiovascular Metabolism, Janssen)
- Nicole L. Daly
(Regulatory Affairs—Neuroscience and Cardiovascular Metabolism, Janssen)
- Juan Fernandes Tajes
(Lund University, Skåne University Hospital)
- Giuseppe N. Giordano
(Lund University, Skåne University Hospital)
- Paul W. Franks
(Lund University, Skåne University Hospital
Umeå University
Harvard T.H. Chan School of Public Health)
Abstract
Prediabetes is a state of glycaemic dysregulation below the diagnostic threshold of type 2 diabetes (T2D). Globally, ~352 million people have prediabetes, of which 35–50% develop full-blown diabetes within five years. T2D and its complications are costly to treat, causing considerable morbidity and early mortality. Whether prediabetes is causally related to diabetes complications is unclear. Here we report a causal inference analysis investigating the effects of prediabetes in coronary artery disease, stroke and chronic kidney disease, complemented by a systematic review of relevant observational studies. Although the observational studies suggest that prediabetes is broadly associated with diabetes complications, the causal inference analysis revealed that prediabetes is only causally related with coronary artery disease, with no evidence of causal effects on other diabetes complications. In conclusion, prediabetes likely causes coronary artery disease and its prevention is likely to be most effective if initiated prior to the onset of diabetes.
Suggested Citation
Pascal M. Mutie & Hugo Pomares-Millan & Naeimeh Atabaki-Pasdar & Nina Jordan & Rachel Adams & Nicole L. Daly & Juan Fernandes Tajes & Giuseppe N. Giordano & Paul W. Franks, 2020.
"An investigation of causal relationships between prediabetes and vascular complications,"
Nature Communications, Nature, vol. 11(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18386-9
DOI: 10.1038/s41467-020-18386-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-18386-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.